ResearcherAnkara Bilkent City HospitalActive in the last 2 years

Berkay Yeşilyurt

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0130-7111; OpenAlex author ID A5050172567. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/14796694.2026.2732589 ↗
HALP–GRIms Synergy Offers Superior Prognostic and Predictive Precision in Advanced Pancreatic Ductal Adenocarcinoma Co-author DOI 10.21203/rs.3.rs-7277845/v1 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Fahriye Tuğba Köş · 2 shared papers, 2025–2026 · strength 0.93
- Paper Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma. DOI 10.1080/14796694.2026.2732589 ↗
- Paper HALP–GRIms Synergy Offers Superior Prognostic and Predictive Precision in Advanced Pancreatic Ductal Adenocarcinoma DOI 10.21203/rs.3.rs-7277845/v1 ↗
İsmet Seven · 2 shared papers, 2025–2026 · strength 0.93
- Paper Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma. DOI 10.1080/14796694.2026.2732589 ↗
- Paper HALP–GRIms Synergy Offers Superior Prognostic and Predictive Precision in Advanced Pancreatic Ductal Adenocarcinoma DOI 10.21203/rs.3.rs-7277845/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.